Related Experiment Video
Updated: Mar 8, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
14.4K
PhenX measures for phenotyping rare genetic conditions.
Michael Phillips1, Tracey Grant1, Philip Giampietro2
1RTI International, Research Triangle Park, North Carolina, USA.
Summary
The PhenX Toolkit now offers 16 new measures for rare genetic conditions, enhancing research standardization. These expert-selected protocols aid in comparing studies and advancing scientific discovery in genetics.
Area of Science:
- Genetics and Genomics
- Biomedical Research
- Rare Diseases
Background:
- The PhenX Toolkit is a vital online resource for standardized phenotype and exposure measures.
- Research into rare genetic conditions requires reliable and consistent assessment tools.
Purpose of the Study:
- To introduce 16 new measures specifically designed for assessing rare genetic conditions within the PhenX Toolkit.
- To expand the PhenX Toolkit's capacity to support research across the lifespan for rare genetic disorders.
Main Methods:
- A working group of domain experts, with community input, selected the new measures and protocols.
- Measures were chosen for their applicability to various life stages and specific rare genetic conditions.
Main Results:
- Sixteen new measures for rare genetic conditions are now available in the PhenX Toolkit.
- These measures include clinical scales, bioassays, questionnaires, and protocols for specific conditions.
- The new measures complement existing PhenX data for anthropometrics, demographics, and health history.
Conclusions:
- The expanded PhenX Toolkit facilitates standardized assessments for rare genetic conditions research.
- Widespread adoption of these measures will improve cross-study comparisons and statistical power.
- Standardization through PhenX enhances the potential for scientific discovery in rare genetic diseases.
Related Concept Videos
01:33Pleiotropy
43.7K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.7K
01:35Pedigree Analysis
90.3K
Overview
90.3K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
68
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
68
01:29Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
02:46Genetic Screens
5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
77
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
77